COVID‐19 Vaccine Response in People with Multiple Sclerosis - Tallantyre, Emma C.; Vickaryous, Nicola; Anderson, Valerie; Asardag, Aliye Nazli; Baker, David; Bestwick, Jonathan; Bramhall, Kath; Chance, Randy; Evangelou, Nikos; George, Katila; Giovannoni, Gavin; Godkin, Andrew; et al. (Annals of neurology, 2022)
Keywords: Adult; Antibodies, Viral - blood; Antibodies, Viral - drug effects; Antirheumatic Agents - therapeutic use; Blood; CD20 antigen; Cell number; Confidence intervals; Coronaviruses; COVID-19; COVID-19 - prevention & control; COVID-19 vaccines; COVID-19 Vaccines - immunology; Female; Health risks; Health services; Humans; Immune response; Immune system; Immunocompromised Host; Immunosuppressive agents; Lymphocytes; Lymphocytes T; Male; Medical records; Middle Aged; Monoclonal antibodies; Multiple sclerosis; Multiple Sclerosis - drug therapy; Multiple Sclerosis - immunology; Respiratory diseases; SARS-CoV-2; Seroconversion; Seroconversion - drug effects; Severe acute respiratory syndrome; Severe acute respiratory syndrome coronavirus 2; Statistical analysis; Therapy; United Kingdom; Vaccines; Viral diseases; United Kingdom